Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

478.83
-9.4300-1.93%
Pre-market: 478.82-0.01500.00%08:30 EST
Volume:432.16K
Turnover:209.61M
Market Cap:10.87B
PE:-36.73
High:499.55
Open:488.30
Low:475.34
Close:488.26
52wk High:615.00
52wk Low:265.00
Shares:22.71M
Float Shares:11.00M
Volume Ratio:1.19
T/O Rate:3.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.0355
EPS(LYR):-21.9007
ROE:-41.22%
ROA:-15.78%
PB:17.38
PE(LYR):-21.86

Loading ...

Ribo and Ribocure Announce Exclusive Global Licensing Agreement With Madrigal for Novel Sirna Therapeutics Targeting Mash

THOMSON REUTERS
·
2 hours ago

BRIEF-Madrigal Expands Its Mash Pipeline With Exclusive Global Licensing Agreement For Six Preclinical Sirna Programs

Reuters
·
2 hours ago

Madrigal, Suzhou Ribo in license deal for liver‑disease programs

Reuters
·
3 hours ago

Madrigal Pharmaceuticals announces exclusive license pact with Suzho Ribo

TIPRANKS
·
3 hours ago

BRIEF-Suzhou Ribo Life Science Signs Exclusive Worldwide Licensing Deal With Madrigal

Reuters
·
3 hours ago

Madrigal Pharmaceuticals Licenses Six siRNA Programs from Ribo Life Science

Reuters
·
3 hours ago

Suzhou Ribo Life Science - Licensing Deal for 6 Pre-Clinical Sirna Programs for Treatment of Metabolic Dysfunction-Associated Steatohepatitis

THOMSON REUTERS
·
3 hours ago

Madrigal Pharmaceuticals Inc - Announces Exclusive Global License Agreement With Suzhou Ribo

THOMSON REUTERS
·
3 hours ago

Madrigal Pharmaceuticals Inc - Ribo to Receive $60 Mln Upfront, Potential $4.4 Bln in Payments

THOMSON REUTERS
·
3 hours ago

A Look At Madrigal Pharmaceuticals (MDGL) Valuation After Recent Share Price Move

Simply Wall St.
·
Feb 08

Madrigal Pharmaceuticals Grants Equity Awards to New Employees

Reuters
·
Feb 06

BRIEF-Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule

Reuters
·
Feb 06

Does Madrigal Pharmaceuticals (MDGL) Offer Value After Recent Share Price Weakness

Simply Wall St.
·
Feb 05

Madrigal Pharmaceuticals Inc. to Release Fourth-Quarter and Full-Year 2025 Financial Results

Reuters
·
Feb 02

Madrigal Builds Commercial Bench With Equity Grants Around Rezdiffra Growth Story

Simply Wall St.
·
Feb 02

Madrigal Pharmaceuticals Inc - and Roche Enter Into First Amendment to Agreement - SEC Filing

THOMSON REUTERS
·
Jan 31

Madrigal Pharmaceuticals Inc - Co Gains Control Over Rezdiffra Patent Term Adjustments - SEC Filing

THOMSON REUTERS
·
Jan 31

Madrigal Pharmaceuticals Gains Patent Control for Rezdiffra in Amended Roche Agreement

Reuters
·
Jan 31

Rezdiffra Sales Milestone and Pfizer DGAT-2 Deal Might Change The Case For Investing In Madrigal Pharmaceuticals (MDGL)

Simply Wall St.
·
Jan 29

Biotech Inventiva's 50% surge shows investor optimism over liver disease drug

Reuters
·
Jan 28